Published :
Tables : 55
Figures : 40
Category : Healthcare
No. of Pages : 200
Report Code : HC-1326
Antiseptic and Disinfectant Market Introduction: Antiseptic and Disinfectant Market is estimated to value over USD 90.02 billion by 2027 end and register a CAGR of over 6.5% during the forecast period 2020 to 2027. Disinfectants and antiseptic are products which are used to prevent the rise of microorganisms when it interacts with an inanimate object or living tissue. An antiseptic is a chemical element which takes control over the growth of microorganisms and a disinfectant is a chemical element that keeps infections at bay by disintegrating micro-organisms that are harmful. There are many advantages associated with disinfectants and antiseptic that include affordability, stability with chemicals and lack of staining with acceptable odor and colour. Disinfectants and antiseptics are used in hospital settings for an array of varied hard surface and topical applications. The antiseptic and disinfectant market growth can be credited the boost in healthcare expenditure, curating innovative healthcare amenities, the surge of hospital related infections and the rise in hygiene maintenance on a global scale. In addition, there are also other components within this market such as the rising use of endoscope reprocessors as well as surgical units containing disinfected sprayers that are automated. Given all these factors, the market is expected to encounter a revitalized economic boost. However, the strict regulatory bodies may pose potential threats to the global market for antiseptic and disinfectant during the forecast timeline. Going by the segmentation of the product, the market is bifurcated into iodine, alcohols, hydrogen peroxide, silver, chlorine compounds, phenolic compounds, aldehydes, quaternary ammonium compounds and others. Phenolic and aldehydes compounds are projected to grow at an exponential rate. In the case of phenolic compounds, there are a number of advantages associated with it in comparison to hydrogen peroxide. In terms of the end user, the is divided into domestic users, healthcare providers and commercial users. The healthcare providers are likely to take control of the market and acquire significant market share. A great deal of utilization of medical instruments, the rise of hospital-related infections, and a surge in the healthcare expenditure in terms of the per capita income in both developed and developing companies alike, are among the components which are anticipated to expand the antiseptic and disinfectant market size. In addition, commercial users of this particular market may further catalyze the industry growth during the forecast time frame because of the effectiveness against bacteria that is vegetative and the associated fungi and viruses. Major players who are dominating the market includes: 3M Company, Novartis Ag, Johnson & Johnson, STERIS plc, Getinge Group, Cardinal Health, Becton, Dickinson And Company, Whiteley Corporation, and Kimberly-Clark. Antiseptic and Disinfectant Market Segmentation: By Product Quaternary Ammonium Compounds Chlorine Compounds Alcohols Aldehydes Phenolic Compounds Hydrogen Peroxide Iodine Silver Others By End-user Healthcare Providers Commercial Users Domestic Users By Region Europe North America Asia Pacific Latin America Middle East & Africa FutureWise Key Takeaways: Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the antiseptic and disinfectant market by product, by end user and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East & Africa To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Antiseptic and Disinfectant Market is estimated to value over USD 90.02 billion by 2027 end and register a CAGR of over 6.5% during the forecast period 2020 to 2027.
Disinfectants and antiseptic are products which are used to prevent the rise of microorganisms when it interacts with an inanimate object or living tissue. An antiseptic is a chemical element which takes control over the growth of microorganisms and a disinfectant is a chemical element that keeps infections at bay by disintegrating micro-organisms that are harmful. There are many advantages associated with disinfectants and antiseptic that include affordability, stability with chemicals and lack of staining with acceptable odor and colour. Disinfectants and antiseptics are used in hospital settings for an array of varied hard surface and topical applications.
The antiseptic and disinfectant market growth can be credited the boost in healthcare expenditure, curating innovative healthcare amenities, the surge of hospital related infections and the rise in hygiene maintenance on a global scale. In addition, there are also other components within this market such as the rising use of endoscope reprocessors as well as surgical units containing disinfected sprayers that are automated. Given all these factors, the market is expected to encounter a revitalized economic boost. However, the strict regulatory bodies may pose potential threats to the global market for antiseptic and disinfectant during the forecast timeline.
Going by the segmentation of the product, the market is bifurcated into iodine, alcohols, hydrogen peroxide, silver, chlorine compounds, phenolic compounds, aldehydes, quaternary ammonium compounds and others. Phenolic and aldehydes compounds are projected to grow at an exponential rate. In the case of phenolic compounds, there are a number of advantages associated with it in comparison to hydrogen peroxide.
In terms of the end user, the is divided into domestic users, healthcare providers and commercial users. The healthcare providers are likely to take control of the market and acquire significant market share. A great deal of utilization of medical instruments, the rise of hospital-related infections, and a surge in the healthcare expenditure in terms of the per capita income in both developed and developing companies alike, are among the components which are anticipated to expand the antiseptic and disinfectant market size. In addition, commercial users of this particular market may further catalyze the industry growth during the forecast time frame because of the effectiveness against bacteria that is vegetative and the associated fungi and viruses.
Major players who are dominating the market includes: 3M Company, Novartis Ag, Johnson & Johnson, STERIS plc, Getinge Group, Cardinal Health, Becton, Dickinson And Company, Whiteley Corporation, and Kimberly-Clark.
Antiseptic and Disinfectant Market Segmentation:
By Product
By End-user
By Region
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global Antiseptic and Disinfectant Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Global Antiseptic and Disinfectant Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Antiseptic and Disinfectant Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Antiseptic and Disinfectant Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Antiseptic and Disinfectant Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Quaternary Ammonium Compounds 7.2. Chlorine Compounds 7.3. Alcohols 7.4. Aldehydes 7.5. Phenolic Compounds 7.6. Hydrogen Peroxide 7.7. Iodine 7.8. Silver 7.9. Others 8. Global Antiseptic and Disinfectant Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Healthcare Providers 8.2. Commercial Users 8.3. Domestic Users 9. North America Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 9.1. Introduction 9.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 9.2.1. U.S.A 9.2.2. Canada 9.2.3. Mexico 9.3. Market Size (USD Million) Forecast for North America 2020-2027 10. Latin America Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 10.2.1. Brazil 10.2.2. Venezuela 10.2.3. Argentina 10.2.4. Rest of Latin America 10.3. Market Size (USD Million) Forecast for Latin America 2020-2027 11. Europe Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 11.2.1. Germany 11.2.2. U.K 11.2.3. France 11.2.4. Italy 11.2.5. Spain 11.2.6. Russia 11.2.7. Poland 11.2.8. Rest of Europe 11.3. Market Size (USD Million) Forecast for Europe 2020-2027 12. Asia Pacific Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 12.2.1. Japan 12.2.2. China 12.2.3. India 12.2.4. Australia and New Zealand 12.2.5. ASEAN 12.2.6. Rest of Asia Pacific 12.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 13. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Saudi Arabia 13.2.2. UAE 13.2.3. South Africa 13.2.4. Egypt 13.3. Market Size (USD Million) Forecast for MEA 2020-2027 14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 14.1. 3M Company 14.1.1. Company Overview 14.1.2. Product Portfolio 14.1.3. SWOT Analysis 14.1.4. Financial Overview 14.1.5. Strategic Overview 14.2. Novartis Ag 14.2.1. Company Overview 14.2.2. Product Portfolio 14.2.3. SWOT Analysis 14.2.4. Financial Overview 14.2.5. Strategic Overview 14.3. Johnson & Johnson 14.3.1. Company Overview 14.3.2. Product Portfolio 14.3.3. SWOT Analysis 14.3.4. Financial Overview 14.3.5. Strategic Overview 14.4. Steris Plc 14.4.1. Company Overview 14.4.2. Product Portfolio 14.4.3. SWOT Analysis 14.4.4. Financial Overview 14.4.5. Strategic Overview 14.5. Getinge Group 14.5.1. Company Overview 14.5.2. Product Portfolio 14.5.3. SWOT Analysis 14.5.4. Financial Overview 14.5.5. Strategic Overview 14.6. Cardinal Health 14.6.1. Company Overview 14.6.2. Product Portfolio 14.6.3. SWOT Analysis 14.6.4. Financial Overview 14.6.5. Strategic Overview 14.7. Becton 14.7.1. Company Overview 14.7.2. Product Portfolio 14.7.3. SWOT Analysis 14.7.4. Financial Overview 14.7.5. Strategic Overview 14.8. Dickinson And Company 14.8.1. Company Overview 14.8.2. Product Portfolio 14.8.3. SWOT Analysis 14.8.4. Financial Overview 14.8.5. Strategic Overview 14.9. Whiteley Corporation 14.9.1. Company Overview 14.9.2. Product Portfolio 14.9.3. SWOT Analysis 14.9.4. Financial Overview 14.9.5. Strategic Overview 14.10. Kimberly-Clark. 14.10.1. Company Overview 14.10.2. Product Portfolio 14.10.3. SWOT Analysis 14.10.4. Financial Overview 14.10.5. Strategic Overview 15. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics